Adam Bryant

Adam Bryant is an accomplished executive with extensive experience in leadership roles across various sectors, including finance and healthcare. Since January 2018, Adam Bryant has served as the Chief Executive Officer of CanSense Ltd, focusing on innovations in cancer diagnostics, particularly in transforming bowel cancer diagnosis. Prior to this role, Adam Bryant was the Executive Chairman of London Block Exchange from August 2017 to January 2019. Additionally, Adam held significant positions at UBS as Head of Macro Sales from April 2016 to September 2017 and at Credit Suisse as Head of Alpha Macro Sales from April 1998 to March 2016.